Cargando…

CRM646-A, a Fungal Metabolite, Induces Nucleus Condensation by Increasing Ca(2+) Levels in Rat 3Y1 Fibroblast Cells

We previously identified a new heparinase inhibitor fungal metabolite, named CRM646-A, which showed inhibition of heparinase and telomerase activities in an in vitro enzyme assay and antimetastatic activity in a cell-based assay. In this study, we elucidated the mechanism by which CRM646-A rapidly i...

Descripción completa

Detalles Bibliográficos
Autores principales: Asami, Yukihiro, Kim, Sun-Ok, Jang, Jun-Pil, Ko, Sung-Kyun, Kim, Bo Yeon, Osada, Hiroyuki, Jang, Jae-Hyuk, Ahn, Jong Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Microbiology and Biotechnology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728397/
https://www.ncbi.nlm.nih.gov/pubmed/31752054
http://dx.doi.org/10.4014/jmb.1908.08043
Descripción
Sumario:We previously identified a new heparinase inhibitor fungal metabolite, named CRM646-A, which showed inhibition of heparinase and telomerase activities in an in vitro enzyme assay and antimetastatic activity in a cell-based assay. In this study, we elucidated the mechanism by which CRM646-A rapidly induced nucleus condensation, plasma membrane disruption and morphological changes by increasing intracellular Ca(2+) levels. Furthermore, PD98059, a mitogen-activated protein kinase (MEK) inhibitor, inhibited CRM646-A-induced nucleus condensation through ERK1/2 activation in rat 3Y1 fibroblast cells. We identified CRM646-A as a Ca(2+) ionophore-like agent with a distinctly different chemical structure from that of previously reported Ca(2+) ionophores. These results indicate that CRM646-A has the potential to be used as a new and effective antimetastatic drug.